Skip to main content

Table 2 Relationships between BAX mRNA expression status and other clinicopathological variables

From: Quantitative expression analysis and prognostic significance of the BCL2-associated Xgene in nasopharyngeal carcinoma: a retrospective cohort study

  

Number of patients (%)

 

Variable

Total

BAX -negativea

BAX -positivea

P value

Cases

88

35 (39.8)

53 (60.2)

 

Gender

    

Male

51

19 (37.3)

32 (62.7)

0.66b

Female

37

16 (43.2)

21 (56.8)

 

Age (years)

    

≤ 30

25

6 (24.0)

19 (76.0)

0.09b

> 30

63

29 (46.0)

34 (54.0)

 

Tumor histology

    

Undifferentiated

46

16 (34.8)

30 (65.2)

0.39b

Non-keratinizing

42

19 (45.2)

23 (54.8)

 

Tumor extent

    

T1 / T2

33

7 (21.2)

26 (78.8)

0.014c

T3

19

8 (42.1)

11 (57.9)

 

T4

36

20 (55.6)

16 (44.4)

 

Regional lymph node status

    

N0

14

7 (50.0)

7 (50.0)

0.024c

N1

14

1 (7.1)

13 (92.9)

 

N2

28

10 (35.7)

18 (64.3)

 

N3

32

17 (53.1)

15 (46.9)

 

Distant metastasis

    

M0

51

19 (31.1)

42 (68.9)

0.018b

M1

27

16 (59.3)

11 (40.7)

 
  1. aCutoff point: 0.43 a.u., equal to the 40th percentile.
  2. bCalculated by chi-square (Χ2) test.
  3. cCalculated by Fisher’s exact test.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us